Palvella Therapeutics (PVLA) Return on Invested Capital (2018)
Historic Return on Invested Capital for Palvella Therapeutics (PVLA) over the last 6 years, with Q3 2019 value amounting to 1.91%.
- Palvella Therapeutics' Return on Invested Capital fell 16900.0% to 1.91% in Q3 2019 from the same period last year, while for Sep 2019 it was 1.91%, marking a year-over-year decrease of 16900.0%. This contributed to the annual value of 0.83% for FY2020, which is N/A changed from last year.
- Palvella Therapeutics' Return on Invested Capital amounted to 1.91% in Q3 2019, which was down 16900.0% from 1.74% recorded in Q2 2019.
- In the past 5 years, Palvella Therapeutics' Return on Invested Capital registered a high of 0.17% during Q2 2018, and its lowest value of 4.08% during Q3 2017.
- In the last 5 years, Palvella Therapeutics' Return on Invested Capital had a median value of 0.68% in 2018 and averaged 1.12%.
- As far as peak fluctuations go, Palvella Therapeutics' Return on Invested Capital soared by 13144100bps in 2015, and later tumbled by -16900bps in 2019.
- Over the past 5 years, Palvella Therapeutics' Return on Invested Capital (Quarter) stood at 0.43% in 2015, then decreased by -22bps to 0.52% in 2016, then plummeted by -271bps to 1.94% in 2017, then soared by 65bps to 0.68% in 2018, then plummeted by -183bps to 1.91% in 2019.
- Its last three reported values are 1.91% in Q3 2019, 1.74% for Q2 2019, and 0.94% during Q1 2019.